Side chain requirements for affinity and specificity in D5, an HIV-1 antibody derived from the VH1-69 germline segment

BMC Biochemistry

Volumn 14, Issue 1, 2013, Pages

  Stewart, Alex ^a   Harrison, Joseph S ^a   Regula, Lauren K ^a   Lai, Jonathan R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; D5 ANTIBODY; HISTIDINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PROLINE; SERINE; TYROSINE; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY LIBRARY; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ARTICLE; CONTROLLED STUDY; MOLECULAR CLONING; NONHUMAN; PHAGE DISPLAY;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; COMPLEMENTARITY DETERMINING REGIONS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; PEPTIDE LIBRARY; PROTEIN STRUCTURE, SECONDARY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84875825670     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-14-9     Document Type: Article

References (45)

1. Therapeutic antibodies: current state and future trends-is a paradigm change coming soon? Dimitrov DS, Marks JD, Methods Mol Biol 2009 525 1 27 10.1007/978-1-59745-554-1-1 19252861
2. Antibody engineering. Maynard J, Georgiou G, Annu Rev Biomol Eng 2001 2 339 376
3. Synthetic therapeutic antibodies. Sidhu SS, Fellouse FA, Nat Chem Biol 2006 2 682 686 10.1038/nchembio843 17108986
4. Understanding mechanisms governing protein-protein interactions from synthetic binding interfaces. Kossiakoff AA, Koide S, Curr Opin Struct Biol 2008 18 499 506 10.1016/j.sbi.2008.06.004 18638552
5. Contribution of light chain residues to high affinity binding in an HIV-1 antibody explored by combinatorial scanning mutagenesis. Da Silva GF, Harrison JS, Lai JR, Biochemistry 2010 49 5464 5472 10.1021/bi100293q 20518570
6. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. Luftig MA, Mattu M, DiGiovine P, Geleziunas R, Hrin R, Barbato G, Bianchi E, Miller MD, Pessi A, Carfi A, Nat Struct Mol Biol 2006 13 740 747 10.1038/nsmb1127 16862157
7. A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. Miller MD, Geleziunas R, Bianchi E, Lennard S, Hrin R, Zhang H, Lu M, An Z, Ingallinella P, Finotto M, Mattu M, Finnefrock AC, Bramhill D, Cook J, Eckert DM, Hampton R, Patel M, Jarantow S, Joyce J, Ciliberto G, Cortese R, Lu P, Strohl W, McElhaugh M, Lane S, Lloyd C, Lowe D, Osbourn J, Vauhan T, Emini E, Barbato G, Kim PS, Hazuda DJ, Shiver JW, Pessi A, Proc Natl Acad Sci USA 2005 102 14759 14764 10.1073/pnas.0506927102 16203977
8. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41. Montgomery DL, Wang Y-J, Hrin R, Luftig M, Su B, Miller MD, Wang F, Hatyko P, Huang L, Vitelli S, Condra J, Liu X, Hampton R, Carfi A, Pessi A, Bianchi E, Joyce J, Lloyd C, Geleziunas R, Bramhill D, King VM, Finnerfrock AC, Strohl W, An Z, Monoclonal Antibodies 2009 1 462 474 20065653
9. Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41. Gustchina E, Li M, Louis JM, Anderson DE, Lloyd J, Frisch C, Bewley CA, Gustchina A, Wlodawer A, Clore GM, PLoS Pathog 2010 11 1001182
10. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Huang CC, Venturi M, Majeed S, Moore MJ, Phogat S, Zhang MY, Dimitrov DS, Hendrickson WA, Robinson J, Sodroski J, Wyatt R, Choe H, Farzan M, Kwong PD, Proc Natl Acad Sci USA 2004 101 2706 2711 10.1073/pnas.0308527100 14981267
11. Antibody recognition of a highly conserved influenza virus epitope. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA, Science 2009 324 246 251 10.1126/science.1171491 19251591
12. Acharya, P, Tang M, Xiang SH, Hussan SS, Stanfield RL, Robinson J, Sodroski J, Wilson IA, Wyatt R, Bewley CR, and Kwong PD: Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Huang CC, Lam SN, Science 2007 317 1930 1934 10.1126/science.1145373 17901336
13. HIV-1 and influenza antibodies: seeing antigens in new ways. Kwong PD, Wilson IA, Nat Immunol 2009 10 573 578 10.1038/ni.1746 19448659
14. Structural and genetic basis for development of broadly neutralizing influenza antibodies. Lingwood D, McTamney PM, Yassine HM, Whittle JRR, Guo X, Boyington JC, Wei CJ, Nabel GJ, Nature 2012 489 566 70 10.1038/nature11371 22932267
15. Rare antibodies from combinatorial libraries suggests an S.O.S. component of the human immunological repertoire. Lerner RA, Mol Biosyst 2011 7 1004 1012 10.1039/c0mb00310g 21298133
16. Molecular recognition by a binary code. Fellouse FA, Li B, Compaan DM, Peden AA, Hymowitz SG, Sidhu SS, J Mol Biol 2005 348 1153 1162 10.1016/j.jmb.2005.03.041 15854651
17. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. Fellouse FA, Esaki K, Birtalan S, Raptis D, Cancasci VJ, Koide A, Jhurani P, Vasser M, Wiesmann C, Koissiakoff AA, Koide S, Sidhu SS, J Mol Biol 2007 373 924 940 10.1016/j.jmb.2007.08.005 17825836
18. The functional capacity of the natural amino acids for molecular recognition. Birtalan S, Fisher RD, Sidhu SS, Mol Biosyst 2010 6 1186 1194 10.1039/b927393j 20383388
19. Synthetic Fab fragments that bind the HIV-1 gp41 heptad repeat regions. Liu Y, Regula LK, Stewart A, Lai JR, Biophys Biochem Res Commun 2011 413 611 615 10.1016/j.bbrc.2011.09.012
20. Manufacturing immunity to disease in a test tube: the magic bullet realized. Lerner RA, Angew Chem Intl Ed 2006 45 8105 8125
21. Synthetic human antibodies and a strategy for protein engineering. Winter G, FEBS Lett 1998 430 92 94 10.1016/S0014-5793(98)00628-0 9678601
22. Two-state selection of conformation-specific antibodies. Gao J, Sidhu SS, Wells JA, Proc Natl Acad Sci USA 2009 106 3071 3076 10.1073/pnas.0812952106 19208804
23. Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design. Gilbreth RN, Truong K, Madu I, Koide A, Wojcik JB, Li NS, Piccirilli JA, Chen Y, Koide S, Proc Natl Acad Sci USA 2011 108 7751 7756 10.1073/pnas.1102294108 21518904
24. Characterization of engineered actin binding proteins that control filament assembly and structure. Brawley CM, Uysal S, Kossiakoff AA, Rock RS, PLoS One 2010 12 13960
25. Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the Ebola virus envelope glycoprotein. Koellhoffer JF, Chen G, Sandesara RG, Bale S, Saphire EO, Chandran K, Sidhu SS, Lai JR, Chembiochem 2012 13 2549 2557 10.1002/cbic.201200493 23111988
26. Synthetic antibodies from a four-amino-acid code: A dominant role for tyrosine in antigen recognition. Fellouse FA, Wiesmann C, Sidhu SS, Proc Natl Acad USA 2004 101 12467 12472 10.1073/pnas.0401786101
27. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. Lee CV, Liang WC, Dennis MS, Eigenbrot C, Sidhu SS, Fuh G, J Mol Bio 2004 340 1073 1093 10.1016/j.jmb.2004. 05.051
28. Humoral immune response to Keyhole Limpet Haemocyanin, the protein carrier in cancer vaccines. Kantele A, Hakkinen MP, Zivny J, Elson CO, Mestecky J, Katele JM, Clin Dev Immunol 2011 2011 614383 21716728
29. Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion. Frey G, Rits-Volloch S, Zhang XQ, Schooley RT, Chen B, Harrison SC, Proc Natl Acad Sci USA 2006 103 13938 13943 10.1073/pnas. 0601036103 16963566
30. Protein design of an HIV-1 entry inhibitor. Root MJ, Kay MS, Kim PS, Science 2001 291 884 888 10.1126/science.1057453 11229405
31. Viral membrane fusion. Harrison SC, Nat Struct Mol Biol 2008 15 690 698 10.1038/nsmb.1456 18596815
32. Mechanisms of viral membrane fusion and its inhibition. Eckert DM, Kim PS, Annu Rev Biochem 2001 70 777 810 10.1146/annurev.biochem.70.1.777 11395423
33. Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides. Chen X, Lu L, Qi Z, Lu H, Wang J, Yu X, Chen Y, Jiang S, J Biol Chem 2010 285 25506 25515 10.1074/jbc.M110.101170 20538590
34. Rapid mapping of protein functional epitopes by combinatorial alanine scanning. Weiss GA, Watanabe CK, Zhong A, Goddard A, Sidhu SS, Proc Natl Acad Sci USA 2000 97 8950 8954 10.1073/pnas.160252097 10908667
35. Alternative views of functional protein binding epitopes obtained by combinatorial shotgun scanning mutagenesis. Pál G, Fong S-Y, Kossiakoff AA, Sidhu SS, Protein Sci 2005 14 2405 2413 10.1110/ps.051519805 16131663
36. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis. Vajdos FF, Adams CW, Breece TN, Presta LG, de Vos AM, Sidhu SS, J Mol Biol 2002 320 415 428 10.1016/S0022-2836(02)00264-4 12079396
37. Comprehensive and quantitative mapping of energy landscapes for protein-protein interactions by rapid combinatorial scanning. Pál G, Kouadio JL, Artis DR, Kossiakoff AA, Sidhu SS, J Biol Chem 2006 281 22378 22385 10.1074/jbc.M603826200 16762925
38. Rosetta3: an object-oriented software suite for the simulation and design of macromolecules. Leaver-Faye A, Tyke M, Lewis SM, Lange OF, Thompson J, Jacak R, Kaufmann KW, Renfrew PD, Smith CA, Sheffler W, Davis IW, Cooper S, Treuille A, Mandell DJ, Richter F, Ban YA, Fleishman SJ, Corn JE, Kim DE, Lyskov S, Berrondo M, Mentzer S, Popovic Z, Havranek JJ, Karanicolas J, Das R, Meiler J, Kortemme T, Gray JJ, Kuhlman B, Baker D, Bradley P, Methods Enzymol 2011 487 545 74 21187238
39. Structural insights into the evolution of an antibody combining site. Wedemayer GJ, Patten PA, Wang LH, Schultz PG, Stevens RC, Science 1997 276 1665 1669 10.1126/science.276.5319.1665 9180069
40. A comparative analysis of the immunological evolution of antibody 28B4. Yin J, Mundorff EC, Yang PL, Wendt KU, Hanway D, Stevens RC, Schultz PG, Biochemistry 2001 40 10764 10773 10.1021/bi010536c 11535051
41. Structural plasticity and the evolution of antibody affinity and specificity. Yin J, Beuscher AE 4th, Andryski SE, Stevens RC, Schultz PG, J Mol Biol 2003 330 651 656 10.1016/S0022-2836(03)00631-4 12850137
42. X-ray snapshots of the maturation of an antibody response to a protein antigen. Li Y, Li H, Yang F, Smith-Gill SJ, Mariuzza RA, Nat Struct Mol Biol 2003 10 482 488 10.1038/nsb930
43. Magnitude of the hydrophobic effect at central versus peripheral sites in protein-protein interfaces. Li Y, Huang Y, Swaminathan CP, Smith-Gill SJ, Mariuzza RA, Structure 2005 13 297 307 10.1016/j.str.2004.12.012 15698573
44. Probing a protein-protein interaction by in vitro evolution. Thom G, Cockroft AC, Buchanan AG, Candotti CJ, Cohen ES, Lowne D, Monk P, Shorrock-Hart CP, Jermutus L, Minter RR, Proc Natl Acad Sci USA 2006 103 7619 7624 10.1073/pnas.0602341103 16684878
45. Chapter 2: Constructing phage display libraries by oligonucleotide- directed mutagenesis. Sidhu SS, Weiss GA, Phage display: a practical approach New York, NY: Oxford University Press, Clackson T, Lowman HB, 27 41